Image default
Business Projects Synthetic Biology

$5.8 billion invested by VC’s in bio-based chemicals; focus shifts to disruptive synthetic biology.

$5.8 billion invested by VCs in bio-based chemicals; focus shifts to disruptive synthetic biology (Pic courtesy of Zymergen Data Science).“VCs have shifted focus this year to commercializing bio-based products that offer improved performance, not just greener replacements for petro-based compounds…”

New research has found that synthetic biology start-ups have raised 53% of all VC funding in bio-based materials and chemicals, as venture firms flock to technology platforms such as DNA synthesis-as-a-service. Venture capitalists have pumped in $5.8 billion into bio-based materials and chemicals (BBMC) start-ups since 2010, reflecting the drive for sustainability, performance, and alternatives to petroleum feedstocks. While from 2010 to 2015, the investment focus was on drop-in replacements for established chemicals, in 2016 VCs focus has shifted to disruptive synthetic biology (synbio) and conversion technologies, according to Lux Research. Synbio startups attracted over $300 million, accounting for 53% of all VC investment in 2016 (up to October 11th ), and three of the top five deals. Fermentation and catalysis had funding shares of 20% and 16%, respectively.

VCs in 2016 have taken a step back in the value chain to focus on upstream technology platforms like DNA synthesis-as-a-service and automated genomic engineering and lab equipment, said Victor Oh, Lux Research Analyst and lead author of the report titled, Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based?

Synbio companies are embracing information technology like BioCAD and BioLIMS to create disruption and to integrate new digital genetic tools like CRISPR gene editing, he added.

$5.8 billion invested by VCs in bio-based chemicals; focus shifts to disruptive synthetic biology. (Source: Lux Research)

Lux Research ( @LuxResearch) analysts built a database of companies and investments in the BBMC space. Among their findings:

  • Synbio poised to grow bigger.The top five VC investments Zymergen, Gingko Bioworks, Twist Bioscience, Elevance Renewable Science and Bolt Threads reveal an emphasis on automating synbio. These five have raised $430 million in total, and growth of these platforms should lead to even bigger numbers for the segment in 2017.
  • Spider silk catches fancy. Spider silks superior properties over those of conventional fiber materials like nylon and silkworm silk have prompted big deals, like $82 million for Bolt Threads over the last two years. Japans Spiber and Germanys AMSilk have also pulled in big deals, and up-and-comers like Araknitek and Spiber Technologies may be up next.
  • Low oil hits drop-ins, substitutes. Amid low oil prices, VCs have shifted focus this year to commercializing bio-based products that offer improved performance, not just greener replacements for petro-based compounds. About 80% of VC investment in 2016 was on improved products, as opposed to only 46% from 2010 to 2015.

The team at LBio-Based World Quarterly Issue #4ux Research have a complimentary webinar coming up, The New Face of Bio-based: How Performance Enables Sustainability in Tomorrows Products, on January 17 at 11:00 EST. And data in this articles is taken from a report, titled Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based? is part of the Lux ResearchBio-based Materials and Chemicals Intelligenceservice.


You may also be interested in…

Synthetic spider silk pioneers receive $50m funding boost.$250m USDA funding pool to help bio-based chemicals and products seeks applications.

Network with leading experts in the bio-based industry by coming along to our nextBio-Based Live Europeevent with confirmed speakers from H&M, Tipa, Carlsberg, Unibio, Ikea, BioBTX and many, many more.

Calling all bio-based projects! The Maine Born Global Challenge wants to hear from you!

USDA reserves $100 Million+ in loan guarantee funding for Biosynthetic Technologies.

Related posts

5 Minutes With… Don McCabe, director of Ontario Federation of Agriculture.

Dave Songer

Avantium opens branch office in Japan to boost development of PEF.

Liz Gyekye

‘Terrifying limbless chickens,’ form part of Boris Johnson’s bizarre view of synthetic biology.

Luke Upton

Leave a Comment

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More